Free for Drug Developers
December 20
Blood Cancer R&D MicroSummit
Quarter 4: Session 3
A hyper-focused Online Experience in 55 minutes
Novel Immunotherapies and Leading Strategies with rapid insights from Large Pharma and Biotech. Learn about new approaches and discuss the latest challenges with like minded peers from across the industry.
By Neo Synth
123
When and Where
Wed, December 20, 2023
10:00 AM - 10:55 AM PDT
Online in 55 minutes
One Window Technology
Speakers & Facilitators
Presentations and Conversation prompts by:
Cedric Dos Santos
Director AML/MDS/MM, Translational Medicine Genentech
Melanie Frigault
VP Translational Medicine Vincerx Pharma
Jim Breitmeyer
Founder & CEO
Oncternal Therapeutics
Simone Filosto
Director, Translational Medicine
Kite/Gilead
Pietro Taverna
VP Research & Translational Medicine
Karyopharm
Stefano Sammicheli
Director
Ichnos Sciences
Presentations
There are three types of highly curated content:
Pipeline Updates & Insights
Teaser videos about the latest in the pipelines of large drug developers, presented by leading experts.
New Innovations
Biotechnology innovations from the pipelines of small to mid-sized pharma
Conversation Prompts
Strategic Peer to Peer Problem solving prompted by video questions.
How it Works
Prepare for the Micro Summit by watching the 60 second video below:
